2Mouna B, Saber B, Tijani el H, et al. Primary malignant non- Hodgkin's lymphoma of the breast: a study of seven cases and literature review[-J] . World J Surgl Oncol, 2012,10 :151. 被引量：1
3Arora SK,Gupta N,Srinivasan R,et al. Non-Hodgkin's lympho- ma presenting as breast masses:A series of 10 cases diagnosed on FNAC[-J]. Diagn Cytopathol, 2013,41 (1) : 53-59. 被引量：1
4Aviles A,Neri N,Nambo MJ,et al. The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast[J]. Am J Clin Oncol,2012,35(2) :126-129. 被引量：1
5Li D, Deng J, He H, et al. Primary breast diffuse large B-cell lym- phoma shows an activated B-cell-like phenotype[-J]. Ann Diagn Pathol.,2012,16(5) :335-343. 被引量：1
6Maeshima AM, Taniguchi H,Fukuhara S, et al. Bcl-2, Bcl-6,and the In- ternational Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemo- therapy['J]. Cancer Sci, 2012,10a (10) : 1898-1904. 被引量：1
7Jennings WC, Baker RS, Murray SS, et al. Primary breast lym- phoma the role of mastectomy and the importance of lymph node status[J]. Ann Surg,2007,245(5) :784-789. 被引量：1
8Jeanneret-Sozzi W, Taghian A, Epelbaum R, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study[J]. BMC Cancer, 2008, 8(2) ,86. 被引量：1
9Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast ; prognostic factors and out- comes of a study by the International Extranodal Lymphoma Study Group[J]. Ann Oneol,2008,19(2) :233-241. 被引量：1
10Avils A, Castafieda C, Neri N, et al. Rituximab and dose dense chemotherapy in primary breast lymphoma[J]. Haematologica, 2007,92(8) : 1147-1148. 被引量：1
